Looking backward to move forward: early detection of neurodegenerative disorders.
about
Biomarkers of Parkinson's disease: present and futureWhat do temporal lobe epilepsy and progressive mild cognitive impairment have in common?Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging.Animal models and high field imaging and spectroscopyDiagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human seraDiagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human seraCdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology.Current neuroimaging techniques in Alzheimer's disease and applications in animal modelsNeuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.The Alzheimer's disease neuroimaging initiative.Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study.MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths.Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields.Picomolar Detection of Hydrogen Peroxide using Enzyme-free Inorganic Nanoparticle-based SensorPreservation of cortical sortilin protein levels in MCI and Alzheimer's disease.Physical activity and brain function in older adults at increased risk for Alzheimer's diseaseThe search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses.Gray and white matter changes in subjective cognitive impairment, amnestic mild cognitive impairment and Alzheimer's disease: a voxel-based analysis studyEngagement in reading and hobbies and risk of incident dementia: the MoVIES project.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.Defining at-risk populations for Parkinson's disease: lessons from ongoing studies.Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjectsFunctional alterations in memory networks in early Alzheimer's disease.Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies.The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview.Prodromal Huntington disease as a model for functional compensation of early neurodegenerationCurrent serum lipoprotein levels and FMRI response to working memory in midlife.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.Nonlinear registration of longitudinal images and measurement of change in regions of interestIncreased hippocampal activation in mild cognitive impairment compared to normal aging and ADOxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunctionTensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.Quantitating severity and progression in primary progressive aphasia.In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 miceMicroglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission.Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).
P2860
Q24170134-2BFD58A1-74A6-48AF-9BDE-1BC9D98242A5Q26822658-265F1D51-E37C-46ED-A295-D92190BCCC7DQ27307692-028EBCD1-C2D7-4596-B3B3-A5512BF5B7E5Q28662048-8BF8D272-8BE8-4CF3-B99E-8F303E6A488FQ28731824-346D8349-A39A-4D62-BD58-ADD20C5D5395Q28741834-B6D35BEB-164F-4B08-844E-B5B2E2C4664DQ30279162-9E8DB00F-BFC3-43EF-9EAB-6EB0A1DEF85EQ30576714-2EE63AD6-A495-4EFE-8208-E5A1873A9911Q30989943-C2CA0E75-4748-4BF7-A264-FAB9835182BDQ31030939-44F7B47E-0A4F-4531-8599-E3555E12E101Q31143202-C3571A48-B511-4B5D-A002-B1DF4012D9FAQ33202814-D08884D1-F30F-468E-B937-47F20EE90379Q33369862-4EBF2FA5-9AD2-4FDD-810F-0FE799F2E6C1Q33411170-3804771B-D118-4367-AC12-78D7FD264546Q33575225-6170CD04-A7AC-4446-88E9-5416697B608AQ33683761-FFD60D2D-9496-4461-94C0-B73F30F609C9Q33690344-CFE6DDBB-A2B1-4E5A-85FB-1DB940866095Q33772053-9E1EDBB3-EF0A-4FE6-9288-18653036E2A7Q33875000-8D38E149-ED0A-4AA5-9D1B-A2FB139912E3Q33916487-EC8FB188-EAF2-4E6F-BC26-08CABDAAE67BQ34005078-9E174A1F-9554-45E3-89D4-5A7934DA6D8FQ34027902-9369E19F-A7F8-463A-9FA0-E38C55F46CF8Q34155662-A0C0F895-0625-4460-B75F-0EADFBCF5ACFQ34234632-A6191016-2975-415F-A370-A915E255BCF1Q34271896-9D422759-5DA5-4A39-BF00-A8A7A8F7B4CAQ34565270-1D7492E0-345A-4737-B49D-C655B196B78FQ34578315-3537363E-97F2-493F-AD7A-CC20CC47ED8FQ34681067-7F812F24-BFEA-4E37-86EE-434515A220BFQ34775966-E3C7B6BF-5ADC-4706-A4F1-36E3B3E88B42Q34891961-FA928AFA-8690-461E-A110-BEB2B420FA8EQ34991223-CE76DD48-916C-495D-ACCF-84CB86C0001CQ35046222-556047A0-0FAA-44B6-8698-EEFDD563AAC2Q35105340-6D11BAA3-DBB1-4E4D-9F41-7E9E954F6DB3Q35358475-24BE5894-295B-4DF2-9CDE-FFA8BD7B03BAQ35401597-67DFCEE5-5BB9-45C4-A4FE-F3ADE9317ADDQ35487438-4BB2AC49-1D32-4E17-9314-1BD2F2C3375EQ35523051-B001C79A-07C5-44AF-842C-14D5AB0761ECQ35565488-DC054E5E-4D7E-4A03-9A4D-B5212EDCE759Q35708750-7C672E88-EB23-4350-AB03-33232BCCE196Q35781558-E78D3100-3FE5-45E4-83FD-90D97ED4F09B
P2860
Looking backward to move forward: early detection of neurodegenerative disorders.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Looking backward to move forward: early detection of neurodegenerative disorders.
@ast
Looking backward to move forward: early detection of neurodegenerative disorders.
@en
type
label
Looking backward to move forward: early detection of neurodegenerative disorders.
@ast
Looking backward to move forward: early detection of neurodegenerative disorders.
@en
prefLabel
Looking backward to move forward: early detection of neurodegenerative disorders.
@ast
Looking backward to move forward: early detection of neurodegenerative disorders.
@en
P2860
P356
P1433
P1476
Looking backward to move forward: early detection of neurodegenerative disorders
@en
P2093
Kenneth Marek
P2860
P304
P356
10.1126/SCIENCE.1090349
P407
P577
2003-10-01T00:00:00Z